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ABSTRACT
Consumption of herbal supplements becomes more and more popular in the world. For the sake of public health, enhanced
supervision on those products is needed. A novel sildenafil analogue is detected from two herbal dietary supplements in our laboratory. Its structure has been identified by various NMR techniques, mass spectrum, IR and X-ray diffraction. This compound is
slightly different from sildenafil (Viagra) in the piperazine moiety, where N-methyl group in sildenafil is replaced by N-hydroxyethyl group. Thereby this compound is named as hydroxyhomosildenafil. Noticeably, this compound has not been approved as
medication. Therefore, it is necessary to monitor diverse analogues besides the commercial chemical compounds.
Key words: Herbal supplements, NMR, Mass Spectrum, IR, X-ray Diffraction, sildenafil, hydroxyhomosildenafil

INTRODUCTION
Synthetic chemical drugs adulterated in Traditional
Chinese Medicine Preparations (TCMP) are prohibited
by Law of Pharmaceutical Affairs in Taiwan. Through
the alternative medicine progress, increasing herbal
foods as dietary supplements have been distributed in
the world market. Such kind of products is divided into
two categories in Taiwan, i.e. health food, regulated by
Health Food Control Act, and general food, regulated by
Act Governing Food Sanitation(1). The health care effect
assessment report of health food should be reviewed by
the central competent authority. The reasonable intake
amount and chemical entities of them should be supported
by relevant scientific literature. The Department of
Health has published nine kinds of approved health care
effects currently. Products claiming misrepresented
or exaggerated health care effects will be inspected by
competent authority. Because of firm law regulation on
health food, the labels on so-called dietary supplement
often claim that products are composed of natural herbs
and good for health, in order to make people feel safe
while using them and avoid the regulation of law. As
a result, the global market of dietary supplements is
increasing year by year. Recently, adulterated synthetic
chemicals have been found in health food based on our
survey(2) and those reported in literatures(3-7). Therefore,
cont i nuou s mon itor on t he qu alit y of herbal food
supplements is urgent for protecting public heath.
Two herbal supplements submitted by the local
health bureau were suspected of illegal adulterants.
Product labels indicated the herbal substance, serves as
supplements of nutrition to enforce energy. Sample A
* Author for correspondence. Tel: +886-2-26531239;
Fax: +886-2-26531244; E-mail: linjerhuei@nlfd.gov.tw

is red capsule filled with brown powder and sample B
is blue capsule filled with white powder. Through TLC
screening, sildenafil (1) was identified from sample A
by comparison with reference standard. Sildenafil, a
phosphodiesterased-5 (PDE-5) inhibitor, was approved
for the treatment of erectile dysfunction in 1998 by FDA;
it shared the major market sales before two other PDE-5
inhibitors tadalafil and vardenafil, which were approved
in 2002 and 2003, respectively. The three drugs can be
obtained only with physician’s prescription. Another
compou nd (2) of the same U V spect r um as that of
sildenafil was also detected. The following describes the
structure determination of this unknown chemical.

MATERIALS AND METHODS
I. Materials
Sildenafil citrate from Pfizer Pharmaceutical (Taiwan)
was provided for registration and inspection on Viagra
and yohimbine was purchased from Sigma (St. Louis,
MO, USA). Acetonitrile, methanol, chloroform and
n-butanol of LC grade were purchased from Labscan
(Dublin, Ireland). Glacial acetic acid, potassium bromide
and dimethylsulfoxide-d 6 (DMSO-d 6 ) were purchased
from E. Merck (Darmstadt, Germany). Ethanol (95%)
was produced by Taiwan Tobacco and Liquor Corporation
(Taipei, Taiwan).
II. Methods
(I) Sample Preparation
Sample powder was taken out from one capsule of
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sample A and B respectively and extracted with ethanol
(5 mL) by ultrasonic shaking at room temperature for 30
minutes. After simple filtration, part of the filtrate was
analyzed by thin layer chromatography (TLC), and the
rest was filtered through 0.45 μm syringe filter before
liquid chromatography-tandem mass spectrometry (LC/
MS/MS) analysis.
(II) TLC and UV Spectrophotometry
TLC was performed on TLC plate (20 × 20 cm) coated
with silica gel 60 F 254 (E. Merck), using chloroformethanol (9:1) as a developing system, visualized at UV
254 nm and then sprayed with Dragendorff’s reagent.
The suspected spot on TLC was scrapped, extracted with
ethanol by ultrasonication for 5 minutes. The supernatant
was used for UV measurement scanned by a CARY
50 Conc (Varian Optical Spectroscopy Inc, Mulgrave,
Victoria, Australia)
(III) LC/MS/MS
For LC/MS/MS experiments, the chromatographic
system was conducted on a Waters 2690 Alliance LC
& 996 photodiode detector (PDA) with an Automatic
Liquid Sampler and an Injector (Milford, MA, U.S.A.).
The separation was performed on a Cosmosil 5C18AR (15 cm × 4.6 mm I.D., 5 μm) reverse phase column
(Nacalai Tesque, Kyoto, Japan). The mobile phase was
composed of acetonitrile-methanol-1% acetic acid with
isocratic elution at 17: 25: 58 at a f low rate of 0.5 mL/
min. The injection volume was 10 μ L and the running
time was 35 min. The LC chromatogram collected by
a 996 PDA detector scanned the wavelength from 200
to 350 nm. The split ratio of column eff luent into the
PDA and mass was about 4:1. An approximately 0.1
mL column effluent was introduced into a tandem mass
spectrometer (Quattro Ultima, Micromass, England)
through the positive electrospray ionization interface.
The control of MS/MS system and data acquiring was
performed with MassLynx V4.0 (Micromass). NLFD3/
LM mass spectrum data library used for identification
of adulteration was created by our laboratory for no
commercial LC/MS/MS database available.
The ion source and desolvation temperature were
set at 120°C and 350°C, respectively. The daughter
ion scanning spectra was used as the identification of
the adulterant. Table 1 listed the main tandem mass
parameters used in the screening aphrodisiacs.
(IV) Extraction and Separation of Sildenafil Analogue
Sample B extract was stored at 4°C overnight and
a white crystalline precipitated. After filtration and
washing, the desired product was obtained and used to
perform the following measurement to determine its
structure. IR spectra were achieved on a Jasco FT/IR-480

Table 1. Tandem mass parameters for the screening of sildenafil,
yohimbine and a sildenafil analogue
Sildenafil

Yohimbine

Sildenafil
analogue

475

355

505

Daughter ion (m/z)
Capillary voltage (kV)

3

3

3

Cone voltage (V)

100

80

100

Collision energy (eV)

25

20

20
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3. (C22H26N2O3, MW354.4)

Figure 1. Structures of sildenafil (1), hydroxyhomosildenafil (2) and
yohimbine (3)

plus Fourier Transform Infrared Spectrometer. Mass
spectra were recorded on a VG Platform Electrospray
ESI/MS and Finnigan MAT 95S mass spectrometer.
NMR spectra were recorded on a Varian Unity Inova-500
spectrometer. X-ray diffraction study was carried out
using a Nonious CAD4 Kappa Axis XRD diffractometer.

RESULTS AND DISCUSSION
I. Detection of Sildenafil and its Analogue with TLC and
UV
Samples were a nalyzed with TLC a nd the
conditions were stated as above. After spraying with
the Dragendorff’s reagent, TLC of sample A showed an
orange spot of the same R f value as the sildenafil standard.
Interestingly, another orange spot was shown in both
sample A and B, and its R f value was very close to that
of sildenafil. Those suspected spots were further isolated
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and scanned on the UV–Visible spectrometer. Sildenafil
was easily identified from sample A, and the UV spectra
of another spot isolated from sample A and B, are similar
to sildenafil’s UV spectrum. This analysis indicated the
unknown adulterant might be structurally relevant to
sildenafil and is a sildenafil analogue.
These samples were conducted on GC-MS, but little
information was obtained.
II. Identification of Sildenafil Analogue, Sildenafil and
Yohimbine by LC/MS/MS
To solve t he i ncrea si ng dema nd for detect i ng
aphrodisiac adulterants in the herbal dietary supplements,
we have established a LC/MS/MS simultaneous detection
method. From TLC i nfor mation, we expected the
interference might be less in white-powder sample B,
hence, sample B was chosen to conduct the test firstly.
The positive and negative MS scanning spectra of sample
B extract were obtained by direct injection. The major
peaks were shown at m /z 505.6 ([M + H] +) and 503.6
([M-H] –), establishing a possible formula C23H 32N6O5S,
30 amu, equivalent to CH 2O, more than that of sildenafil.
A daughter ion obtained from positive collision appeared

at m/z 487.5 [M+H-18], indicating a hydroxy group at
the side chain. While a daughter ion from negative
collision appeared at m/z 475.6 [M-H-28], attributed to
the breakdown of the O-ethyl group; similar to that for
sildenafil.
Detailed MS/ MS analysis of cr ystalline 2 was
obtained in order to conf irm the above speculation.
Daughter ion scanning set at m/z 505.5 showed the base
peak at m/z 99 (N-methylpiperazine), major peaks at
m/z 112 (N-ethylpiperazine), 487 ([M+H-H 2O]+) and 461
([487-CH=CH] +). A fragment at m/z 129, equivalent
to N-hydroxyethylpiperazine, is different from that
of sildenafil. These data support 2 to be a sildenafil
analogue with substitution of N-methypiperazine group.
Parent ion chromatograms were obtained to confirm
whether the daughter ion m/z 487, 461 and 377 were
from m/z 505.5. The possible fragmentation pathways are
shown in Figure 2.
Sample A extract was performed as above. Besides
sildenafil and its analogue, another aphrodisiac, yohimbine
(3, retention time 3.5 min.) was found in the total ion
current chromatogram. Yohimbine possesses weak UV
absorption and might be ignored by TLC screening. This
prohibited drug in Taiwan was detected by LC/MS/MS,
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Figure 2. The detailed possible fragmentation pathways of the unknown compound at the LC/MS/MS electrospray positive (ESI+).
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accompanied with sildenafil and sildenafil analogues
within one run.
III. Structure Determination of Sildenafil Analogue 2
The structure of 2 was identified by comparison
of its data (1H and 13 C NMR) with the NMR data of
sildenafil (1). Basically, 1H-NMR and 13C-NMR of 2
were similar to that of 1. The difference of 13C-NMR
spectra between 1 and 2 showed that one primary carbon
signal at δC 44.7 of 1 disappeared and two other obvious
secondary carbons at δC 59.2 and δC 60.3 of 2 appeared.
The 1H-NMR spectra indicated one singlet methyl group
at δH 2.27 of 1 was replaced by two methylene protons at
δH 2.37 and δH 3.41 ppm as well as one hydroxy proton at
δH 4.37 ppm of 2. These data would conclude 2 to possess
N-hydroxyethyl substitution at the piperazyl moiety. The
HMQC spectroscopy data of 2 showed two significant
correlations of δC 59.2/δH 3.41(C30/H30) and δ C 60.3/δH
2.37(C29/H29), and homo-COSY data showed δH 2.37/δH
3.41 (H29/H30) correlation. The HMBC (Figure 3) data
also provided the correlation of δ H 2.37/δ C 59.2, 52.7
(H29/C30, C25, C27); δH 2.45/δC 60.3, 46.6 (H25, 27/C29,
C24, C28); δH 3.41/δC 60.3 (H30/C29) and δH 4.37/δC 59.2
(HO/C30). Based on these 2D data, the structure of 2
was confirmed. Table 2 summarizes the NMR data of 2.

Although 2 was not approved as a medicine, it had been
found in the Netherlands(6) and Japan markets(7). Blok-Tip
et al., named as hydroxyhomosildenafil.
To elucidate the stereochemical structure, the crystal
2 was also performed on an X-ray diffractometer. Figure
4 shows the X-ray structure analysis of 2. The crystal
belongs to the triclinic system, space group Pī, and its unit
cell dimension are as follows: a = 8.02350 Å, b = 11.3660
Å, c = 14.8470 Å, α = 74.9440, β = 83.8780, γ = 76.1770.

CONCLUSIONS
By application of NMR techniques and from MS
spectra, IR spectra, this analogue was identif ied as
hydoxyhomosildenafil. Because its structure is similar to
that of sildenafil, it might present PDE-5 inhibition based
on structure activity relationship. Without labels on the
product and no relative toxicity were published, this illegal
adulterant is dangerous to consumers if it has some side
effect. We suspect that there is a tendency of synthesizing
var ious sildenaf il analog ues for avoidi ng possible
supervision around the world. Continuous monitoring
Table 2. NMR data of compound 2 (DMSO- d6)
No.

1

H (ppm)

1

HMBC
H-11/H-12

154.5

6

148.9

H-15

8

138.5

H-11

125.1

H-10

10

4.17 (3H, S)

11

2.77 (2H, t, J = 7.0 Hz)

27.9

H-12

H-12/H-13

12

1.75 (2H, m)

22.4

H-11/H-13

H-11/H-13

13

0.95 (3H, t, J= 7.03 Hz)

14.5

H-12

H-11/H-12

14

38.6

126.5

H-18

130.7

H-17

16

124.6

H-15/H-17/
H-18

17

7.83 (1H, dd, J=8.5, 2 Hz) 132.2

H-18

18

7.38 (1H, d, J= 8.5 Hz)

H-17

15

7.84 (1H, d, J=2 Hz)

19

Figure 4. The X-ray diffractometeric picture of compound 2.

COSY

12.20 (1H, br.s)

9
Figure 3. The major HMBC spectra of compound 2.

C
(ppm)
145.7

4
5

13

113.9

H-15
H-15/H-17/
H-18/H-20

160.6

20

4.21 (2H, q, J= 7 Hz)

65.6

H-21

H-21

21

1.34 (3H, t, J= 7 Hz)

15.0

H-20

H-20

24, 28 2.89 (4H, br.s)

46.6

H-25/H-27 H-25/ H-27

25, 27 2.45 (4H, br, m)

52.7

H-24, H-28

H-24/
H-28/H-29

29

2.37 (2H, t, J= 6.3 Hz)

60.3

H-30

H-25/H-27

30

3.41 (2H, t, J= 5.3 Hz)

59.2

H-29

H-29
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and developing new methods to detect the diverse
illegal compounds adulterated in herbal supplements are
necessary and risk assessments of medicine analogues
are proposed in the view of public health. Fur ther
quantitative analysis of this adulterant in sample A and B
is in progress.
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